Suggestions
Kevin Chandler
Assistant Professor, Translational Glycobiology Institute, Dept. of Translational Medicine at Florida International University - Herbert Wertheim College of Medicine
Professional Background
Kevin Brown Chandler is an accomplished researcher and Assistant Professor at the Translational Glycobiology Institute, within the Department of Translational Medicine at Florida International University - Herbert Wertheim College of Medicine. With a profound interest in the applications of mass spectrometry to study protein modifications, particularly in the context of various diseases, Kevin has distinguished himself as a leading figure in the field of glycobiology and cancer research. His career trajectory is marked by significant positions at esteemed institutions such as Boston University, where he has previously served as an Instructor and Postdoctoral Fellow, contributing to cutting-edge research in biochemistry, analytical chemistry, and tumor biology.
His research primarily focuses on the mechanistic understanding of protein glycosylation and its effects on cellular signaling and adhesion, especially in cancer pathology. His long-term research objectives include improving cancer diagnosis and treatment through enhanced comprehension of glycosylation's role in key signaling pathways, such as VEGFR2 and EGFR. Kevin’s commitment to elucidating these complex biological interactions has positioned him at the forefront of efforts to bridge fundamental research and clinical applications in oncology.
Education and Achievements
Kevin's educational background lays a strong foundation for his research endeavors. He earned a Ph.D. in Biochemistry and Molecular & Cellular Biology from Georgetown University, where he cultivated essential skills in biochemical research and theory. Prior to this, he completed his Bachelor of Science in Biochemistry and Molecular Biophysics at the University of Arizona. Furthering his research expertise, Kevin pursued postdoctoral studies at Boston University, focusing on angiogenesis, post-translational modifications, and mass spectrometry. This rigorous academic training has not only equipped him with advanced insights into biochemistry but has also fostered a collaborative spirit that underpins his research philosophy.
Throughout his academic journey, Kevin has actively sought opportunities for collaboration across disciplines of proteomics and glycobiology. His proficiency in mass spectrometry techniques, particularly in the analysis of glycoproteins and glycopeptides, allows him to contribute significantly to the understanding of tumor microenvironments and cancer cell behavior.
Notable Research Contributions
In his current role, Kevin is investigating the critical role of N-glycosylation in two central areas of cancer research: (1) the VEGFR2-mediated angiogenic signaling pathway in colorectal cancer, and (2) the epidermal growth factor receptor (EGFR) signaling pathway in oral squamous cell carcinoma (OSCC). His research clarifies how modifications in glycosylation patterns can influence key signaling events that promote tumor progression and metastasis.
One of Kevin’s notable contributions lies in his exploration of the relationship between sialic acid modifications and VEGFR2 signaling. His research provides a vital connection between immune responses and angiogenic signaling, indicating how tumor cells manipulate glycoconjugates to enhance their survival and growth prospects in hostile environments. These findings have garnered recognition from leaders in angiogenesis research and contribute to the growing understanding of how glycosylation impacts cancer pathology.
Kevin's dedication extends beyond his research; he actively participates in mentorship roles, guiding students and aspiring researchers in the fields of biochemistry and mass spectrometry. His collaborative approach encourages innovation and fosters a dynamic research environment that promotes learning and scientific inquiry.
Special Skills and Interests
Kevin possesses a specialized skill set that encompasses a range of techniques and theoretical knowledge in biochemistry and analytical chemistry. His expertise includes mass spectrometry, receptor tyrosine kinase glycosylation analysis, and in-depth studies of glycoproteins. He is particularly adept at MS/MS of glycopeptides, which further extends his contributions to the field.
In summary, Kevin Brown Chandler stands out as a prominent figure in the realms of glycobiology and cancer research. With his comprehensive educational background, robust research experience, and commitment to collaboration, he is well-positioned to make significant advances in understanding the mechanisms through which protein modifications affect cancer development and treatment. His ongoing research endeavors reflect his passion for science and his aspiration to translate fundamental research into tangible clinical benefits. Kevin continues to champion the critical connection between glycobiology and cancer research, aiming to shape the future of cancer diagnosis and therapy.
Achievements to be included here if available.
